NM_004820.5:c.169G>T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_004820.5(CYP7B1):c.169G>T(p.Gly57*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004820.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP7B1 | NM_004820.5 | c.169G>T | p.Gly57* | stop_gained | Exon 2 of 6 | ENST00000310193.4 | NP_004811.1 | |
CYP7B1 | NM_001324112.2 | c.169G>T | p.Gly57* | stop_gained | Exon 2 of 7 | NP_001311041.1 | ||
CYP7B1 | XM_017014002.2 | c.235G>T | p.Gly79* | stop_gained | Exon 3 of 7 | XP_016869491.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly57*) in the CYP7B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP7B1 are known to be pathogenic (PMID: 9802883, 19363635, 19439420, 21541746, 21567895, 28039895). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CYP7B1-related conditions. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.